Core Viewpoint - MD Anderson Cancer Center is recruiting postdoctoral researchers to advance cutting-edge single-cell multi-omics technologies and explore molecular regulatory networks in cancer development and drug resistance [3][8]. Group 1: Research Focus - The laboratory aims to develop single-cell multi-omics technologies, investigate the epigenetic regulatory mechanisms of cancer cell plasticity, and understand the epigenetic basis of individualized drug responses [3]. - The research group is led by Dr. Zhang Bingjie, who has a strong background in epigenomics and single-cell multi-omics [2]. Group 2: Institutional Overview - MD Anderson Cancer Center is a leading cancer treatment and research institution, consistently ranked as the top cancer specialty by U.S. News & World Report, located in Houston, Texas [8]. - The center has conducted over 1,680 clinical trials in 2024, with 22 drugs approved by the FDA and research funding amounting to $1.1 billion [8]. Group 3: Application Requirements - The position is for two postdoctoral researchers in genomics and tumor biology, requiring a Ph.D. in relevant biological fields [9][10]. - Candidates with backgrounds in tumor biology, genomics, and computational biology are preferred, along with strong communication and teamwork skills [10][11].